BioLargo Inc strengthens balance sheet by eliminating nearly all of its convertible debt
BioLargo strengthens balance sheet by eliminating nearly all of its convertible debt It recently paid off $406,000 in convertible debt that would have come due in August 2021 through cash and equity CEO Dennis Calvert noted that BioLargo had $7.6 million in debt just three years ago BioLargo Inc (OTCQB:BLGO) reports that it has eliminated nearly all of its convertible debt to strengthen its balance sheet. The company paid off $406,000 in convertible debt that would have come due in August 2021, through cash and equity. Other than the debt owed by its partially-owned subsidiary ...